It was approved by the FDA in 2002 for the treatment of postmenopausal women and men with osteoporosis who are at high risk of fracture
Patients assigned to tirzepatide showed a 20.9% BW loss after 36 weeks with an additional 5.5% reduction after 52 weeks, while those who switched to placebo experienced a 14% weight regain, confirming the findings from STEP 4 supporting the chronicity of obesity and the need for continuous treatment
You can cycle off for an equal duration before starting another round if needed
But, the catch is it requires a minimum deposit of $5,000
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
Immunity Plus Drip includes: Vitamin C (10,000mg): At a higher dose for added immune power